Bayer AG (BAYRY)
7.60
0.00 (0.00%)
USD |
OTCM |
May 03, 16:02
Bayer Revenue (Quarterly): 12.77B for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 12.77B |
| September 30, 2023 | 11.26B |
| June 30, 2023 | 12.04B |
| March 31, 2023 | 15.45B |
| December 31, 2022 | 12.27B |
| September 30, 2022 | 11.36B |
| June 30, 2022 | 13.65B |
| March 31, 2022 | 16.43B |
| December 31, 2021 | 12.72B |
| September 30, 2021 | 11.53B |
| June 30, 2021 | 13.08B |
| March 31, 2021 | 14.86B |
| December 31, 2020 | 11.92B |
| September 30, 2020 | 9.947B |
| June 30, 2020 | 11.07B |
| March 31, 2020 | 14.18B |
| December 31, 2019 | 11.90B |
| September 30, 2019 | 10.93B |
| June 30, 2019 | 12.03B |
| March 31, 2019 | 13.92B |
| December 31, 2018 | 11.81B |
| September 30, 2018 | 10.77B |
| June 30, 2018 | 11.32B |
| March 31, 2018 | 11.23B |
| December 31, 2017 | 10.12B |
| Date | Value |
|---|---|
| September 30, 2017 | 9.434B |
| June 30, 2017 | 9.588B |
| March 31, 2017 | 10.31B |
| December 31, 2016 | 9.518B |
| September 30, 2016 | 9.217B |
| June 30, 2016 | 13.37B |
| March 31, 2016 | 13.08B |
| December 31, 2015 | 12.35B |
| September 30, 2015 | 12.23B |
| June 30, 2015 | 13.26B |
| March 31, 2015 | 13.40B |
| December 31, 2014 | 13.48B |
| September 30, 2014 | 13.21B |
| June 30, 2014 | 14.03B |
| March 31, 2014 | 14.46B |
| December 31, 2013 | 13.46B |
| September 30, 2013 | 12.78B |
| June 30, 2013 | 13.53B |
| March 31, 2013 | 13.55B |
| December 31, 2012 | 12.79B |
| September 30, 2012 | 12.08B |
| June 30, 2012 | 13.05B |
| March 31, 2012 | 13.18B |
| December 31, 2011 | 12.38B |
| September 30, 2011 | 12.25B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
9.947B
Minimum
Sep 2020
16.43B
Maximum
Mar 2022
12.60B
Average
12.04B
Median
Jun 2023
Revenue (Quarterly) Benchmarks
| Affimed NV | 0.4448M |
| InflaRx NV | 0.0025M |
| MorphoSys AG | 63.62M |
| BioNTech SE | 1.593B |
| Immatics NV | 17.15M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.440B |
| Total Expenses (Quarterly) | 2.422B |
| EPS Diluted (Quarterly) | 0.3688 |
| Enterprise Value | 64.35B |
| Gross Profit Margin (Quarterly) | 62.18% |
| Profit Margin (Quarterly) | 11.27% |
| Earnings Yield | -10.88% |
| Operating Earnings Yield | 28.76% |
| Normalized Earnings Yield | -10.88 |